got pregnant while taking tirzepatide Pregnancy & Tirzepatide: Safety Concerns & Next Steps Tirzepatide and Pregnancy: Safety, Risks,

masks hypoglycemia symptoms in diabetics Respiratory: Rare bronchospasm (less likely due to 1 selectivity) Others: Cold extremities, sleep disturbances Contraindications Severe bradycardia Heart block (2nd/3rd degree) Decompensated heart failure Severe asthma or COPD (use caution) Drug Interactions Other antihypertensives additive hypotension Antiarrhythmics additive bradycardia / AV block NSAIDs may reduce antihypertensive effect Class: Cardioselective 1-blocker Effect: HR, contractility, BP Major adverse effects: Bradycardia, hypotension, fatigue Uses: Hypertension, angina, post-MI, arrhythmias Mnemonic for Beta-Blocker Effects (HR & BP): BB lowers BP & beats (HR) To view or add a comment, sign in Beta Blockers Definition Beta blockers are drugs that block -adrenergic receptors, reducing the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) on the heart, lungs, and vasculature

Lilly starts Phase 3 plan for orforglipron in OA + obesity [5] [05 Sep 2025] Context: Interventional, randomized, parallel, single-blind design

Key topics included the effectiveness of oral semaglutide in clinical practice, the positioning of the agent to optimize the treatment benefits, the possibility to adopt flexibility in the administration schedule, critical issues encountered, the role of patient communication and information in the importance of dose escalation and management of adverse events

It presents these as coordinated clinical decisions rather than something a patient manages alone

In base alle analisi - pubblicate nella Cochrane Library, considerata un'autorit nei processi di revisione della letteratura scientifica sugli effetti degli interventi sanitari - semaglutide, liraglutide e tirzepatide sono strumenti molto efficaci nella lotta all'obesit, ma rimangono ancora tre punti critici su cui lavorare, prima che se ne possa auspicare una diffusione su larga scala

Despite the expenses related to the medication, many patients find Semaglutide GLP-1 to be a valuable investment due to its potential to facilitate weight loss comparable to surgical alternatives, which may come with higher costs, considerable downtime, and a higher risk of side effects